Maithé TAUBER, MD
University Hospital, Toulouse
6
6
4
N/A
0
7
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+2 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (6)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
HS Kim, M.D.
Sinchon severance hospital
Shared therapeutic areas:
SH Park, M.D.
St Vincent's Hospital
Shared therapeutic areas:
YJ Lee, M.D.
Korea University
Shared therapeutic areas:
David Meeker, MD
Rhythm Pharmaceuticals, Inc.
Shared therapeutic areas:
CW Ko, M.D.
Kyungpook National University Hospital
Shared therapeutic areas:
SY Lee, M.D.
SMG-SNU Boramae Medical Center
Shared therapeutic areas:
JY Seo, M.D.
Eulji General Hospital
Shared therapeutic areas:
Jean-Olivier ARNAUD, Director
Assistance Publique Hôpitaux de Marseille
Shared therapeutic areas:
CY Kim, M.D.
daejin medical center
Shared therapeutic areas:
JS Yu, M.D.
Dankook University
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (6)
Showing 6 of 6 trials
Long-term Interventional Follow-up Study of Children With Prader-Willi Syndrome Included in the OTBB3 Clinical Trial
Ghrelin in Patients With a Rare Disease Associated With Intellectual Disability, and Hyperphagia, and/or Overweight, and/or Obesity
Study of Emotion and Cognition Abilities of Children With PWS and Proposition of an Innovative Remediation
Oxytocin Treatment in Neonates and Infants With Prader-Willi Syndrome
Effects of Intranasal Administration of Oxytocin in Adults With Prader-Willi Syndrome
Is There a Sensibility Increased in the Growth Hormone at Child With Prader-Willi Syndrome?
All 6 trials loaded